Structure Therapeutics is expected to release Phase 2B obesity data for aleniglipron by the end of 2025. The company’s next earnings report is scheduled for August 7, 2025.

Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos ...

Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...

Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, ...

Peptides are gaining a lot of attention in various fields of research- medicine, biology, and cosmetics sciences- much i ...

A new obesity drug combining four hormones may outperform Wegovy and Mounjaro. Learn what it means for health, science, and investors.

The chemical was strong enough to leave a mark at 51st and Ludlow and leave the victim with second and third-degree burns to her face, legs, arms, neck and torso. The victim, 25-year-old Diana, is ...

Legal battle over semaglutide between Novo Nordisk and Indian drugmakers will set precedent for future opportunities and exports.

Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their risk of developing neovascular age-related macular degeneration (nAMD ...

Stavian Chemical Joint Stock Company has secured the 15th spot globally and maintained the 7th place in the Asia-Pacific region in the ICIS Top 100 Chemical Distributors 2025 ranking, affirming ...